Clin Mol Hepatol.
2023 Oct;29(4):1050-1051. 10.3350/cmh.2023.0310.
Correspondence on Letter regarding “Risk factors in nonalcoholic fatty liver disease”
- Affiliations
-
- 1Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea
- 2Hanyang Institute of Bioscience and Biotechnology, Hanyang University, Seoul, Korea
- KMID: 2546393
- DOI: http://doi.org/10.3350/cmh.2023.0310
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Correspondence on Letter regarding “Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF-κB signaling pathways”
- Prevalence of the Nonalcoholic Fatty Liver Disease in Obese Children
- Noninvasive serum biomarkers for liver steatosis in nonalcoholic fatty liver disease: Current and future developments
- Nonalcoholic fatty liver disease: pathogenesis and treatment
- Letter regarding “Risk factors in nonalcoholic fatty liver disease”
